1Wang YX, Xu X, Luo C, et al. A putative domain target for anti-hepatitis B virus: Residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306). J Med Virol, 2007, DOI 10. 1002/jmv.
2Boume CR, Finn MG, Zlotnick A. Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1. J Virol,2006, 80:11055- 11061.
3Ma S, Boemer JE, Tiong Yip C, et al. NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis c virus alone or in combination with alpha interferon. Antimicrob Agents Chemother,2006, 50:2976 - 2982.
4Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol, 2005, 79 : 9369 - 9380.
5Barber DL, Wherry El, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 2006, 439:682 - 687.
6Biswal BK, Chemey MM, Wang M, et al. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggested mechanisms of inhibition by non-nucleoside inhibitors. J Biol Chem 2005, 280:18202 - 18210.
